fbpx

Resources

Feb 1, 2022

February is National Age- Related Macular Degeneration (AMD) & Low Vision Month

February is national age-related macular degeneration (AMD) and low vision awareness month. AMD is the leading cause of low vision and blindness in Americans age 60 years and older and…

February is National Age- Related Macular Degeneration (AMD) & Low Vision Month

Feb 1, 2022

FDA approves Vabysmo for treatment of wet AMD, DME

The FDA has approved Vabysmo for the treatment of wet age-related macular degeneration and diabetic macular edema, according to a press release from Genentech. Vabysmo (faricimab-svoa) is an injectable eye medicine…

FDA approves Vabysmo for treatment of wet AMD, DME

Jan 28, 2022

Open Your Eyes Podcast Hosted by Dr. Kerry Gelb

Coming Monday, January 31st. A F I L M B Y W A Y N E C H E S L E R Open Your Eyes follows Dr. Kerry Gelb…

Open Your Eyes Podcast Hosted by Dr. Kerry Gelb

Jan 28, 2022

Friday Fun Eye Facts

Did You Know? It’s impossible to sneeze with your eyes open

Friday Fun Eye Facts

Jan 27, 2022

iPhone has color filters for those with vision loss

Did you know? If you have an iPhone, go to settings, select accessibility, scroll down to display and text size, then choose color filters. This is a great way to…

iPhone has color filters for those with vision loss

Jan 26, 2022

Don’t panic! Screens will not make you go blind

By Connor Hopkins Selling “miracle cures” seems to be as American as apple pie or baseball, and in an age where people are more health-conscious than ever before, the world…

Don’t panic! Screens will not make you go blind

Jan 21, 2022

Friday Fun Eye Facts

Did you know? Your eyes focus on 50 different objects every second.

Friday Fun Eye Facts

Jan 11, 2022

Nutritional Supplements for Glaucoma

Dietary recommendations for when your patients ask, “What else can I do?” By: Lisa Hornick, OD, FAAO & Kristyna Lensky Sipes, OD- Permission given by Dr. Hornick to share this…

Nutritional Supplements for Glaucoma

Jan 4, 2022

Dr. Mali’s top 5 predictions in ophthalmology for 2022

December 27, 2021 by: Joshua Mali, MD In light of another unprecedented year filled with technological advancements and pivots as a result of the pandemic, Joshua Mali, MD, offers his…

Dr. Mali’s top 5 predictions in ophthalmology for 2022

Dec 27, 2021

Smoking, Alcohol Cessation and Ocular Health: How Quitting Can Save Your Patients’ Vision

Although genetics play a role, clinicians have a responsibility to influence all patients to moderate alcohol use and cease smoking. by: K. Patricia Bouweraerts, MA Reception areas at ophthalmologists’ offices…

Smoking, Alcohol Cessation and Ocular Health: How Quitting Can Save Your Patients’ Vision

Dec 20, 2021

Wet AMD home monitoring systems provide high-quality scans

by: Lynda Charters Patients can get real-time disease monitoring with self-operated device. Reviewed by Anat Loewenstein, MD The feasibility of Home OCT monitoring (Notal Vision, Inc) with a patient self-operated…

Wet AMD home monitoring systems provide high-quality scans

Dec 16, 2021

Association of smoking, alcohol consumption, blood pressure, BMI, and glycemic risk factors with AMD

Kuan V, Warwick A, Hingorani A, et al JAMA|December 16, 2021 Results from this study lend support to a potential causal association of alcohol intake with an elevated risk of…

Association of smoking, alcohol consumption, blood pressure, BMI, and glycemic risk factors with AMD

Dec 5, 2021

Impact of Age-related Macular Degeneration Survey

Background to study: Approximately 11 million people are living with age-related macular degeneration (AMD) in the United States. Yet despite this, up-to-date data regarding the impact on individuals, their families…

Impact of Age-related Macular Degeneration Survey

Dec 3, 2021

New Eye Drop for Presbyopia: You bet!

By Dr. Joshua Mali Allergan, an AbbVie company, announced FDA approval of pilocarpine HCl ophthalmic solution 1.25% (VUITY) for the treatment of presbyopia, commonly known as age-related blurry near vision,…

New Eye Drop for Presbyopia: You bet!

Nov 18, 2021

NEI aims to eliminate vision loss, improve quality of life with strategic plan

Over the next 5 years, the National Eye Institute is aiming to eliminate vision loss and improve quality of life through vision research, according to a press release from the…

NEI aims to eliminate vision loss, improve quality of life with strategic plan

Nov 17, 2021

First Alternative to Eye Injections for Age-related Macular Degeneration Shown Effective

New study shows refillable implant works as well as eye injections to treat blinding eye disease NEW ORLEANS, La. – An implant that delivers medication to the back of the eye…

First Alternative to Eye Injections for Age-related Macular Degeneration Shown Effective

Nov 16, 2021

FDA-approved eye drops target presbyopia patients

Cathleen McCabe, MD, discusses VUITY, the first and only FDA-approved eye drop to treat age-related blurry near vision, and how it provides opportunities for patients looking for spectacle independence. Cathleen…

FDA-approved eye drops target presbyopia patients

Nov 11, 2021

RESEARCHERS DISCOVER NEW TYPE OF NERVE CELL IN THE RETINA

The newly identified Campana cell could play a role in visual signal processing. Scientists at the John A. Moran Eye Center at the University of Utah have discovered a new type of…

RESEARCHERS DISCOVER NEW TYPE OF NERVE CELL IN THE RETINA

Nov 11, 2021

The Anti-AMD Diet

The Anti-AMD Diet Written by: Michelle Milgrim, MS RD CDN, Manager Employee Wellness, Northwell Health. Jennifer Young, Dietetic Intern, Northwell Health. Can an orange a day really keep macular degeneration…

The Anti-AMD Diet

Nov 4, 2021

FDA approves Bausch + Lomb and Clearside’s XIPERE for macular edema

FDA Approved by: Alex Delaney-Gesing The FDA has approved XIPERE for the treatment of macular edema associated with uveitis The FDA approved XIPERE (triamcinolone acetonide injectable suspension) for suprachoroidal use.…

FDA approves Bausch + Lomb and Clearside’s XIPERE for macular edema

Nov 3, 2021

Researchers are finding new ways to restore patient’s sight

by: Ruthann Richter Among the research projects that Stanford Medicine scientists are running to help people regain lost functions of the brain or nervous system are some designed to help people with…

Researchers are finding new ways to restore patient’s sight

Nov 1, 2021

The link between sleep deprivation and chronic disease

By: Naveed Saleh, MD, MS As a physician, chances are that you’ve experienced your fair share of sleepless nights. But, sleep is a cardinal aspect of health, with humans needing to…

The link between sleep deprivation and chronic disease

Oct 29, 2021

Having trouble sleeping? Eating roasted pumpkin seeds can help

BY SHEAH RARBACK SPECIAL TO THE MIAMI HERALD We have entered the season of orange spice. Pumpkins line store aisles and cinnamon scent drifts into our noses. The holiday season is…

Having trouble sleeping? Eating roasted pumpkin seeds can help

Oct 29, 2021

Antidepressant Prozac could offer the first treatment for atrophic macular degeneration

New Study An antidepressant best known as Prozac could offer the first treatment for the leading cause of blindness among people over 50, new research from the University of Virginia…

Antidepressant Prozac could offer the first treatment for atrophic macular degeneration

Oct 20, 2021

Healthy Life: October is National Pumpkin Month

Did you know each year about 655,765 tons of pumpkins are produced? Besides being great Halloween decorations and pies for Thanksgiving dinner, pumpkins can play major roles in health promotion.…

Healthy Life: October is National Pumpkin Month

Oct 20, 2021

Environmental, Behavioral Triggers Linked To Dry Eye Disease Flares

by: Rita Aghjayan Real-world triggers and characteristics of dry eye disease (DED) flares can include environmental factors, such as air conditioning, wind, low humidity, or pollution, as well as behavioral…

Environmental, Behavioral Triggers Linked To Dry Eye Disease Flares

Oct 15, 2021

COVID-19 Delays in Retina Care Are Driving Worse Vision Outcomes

October 10, 2021 Kevin Kunzmann A greater rate of intravitreal injection appointments were delayed last year, causing worse patient scores in BCVA and OTC. Increased delayed care for ophthalmic intravitreal injection…

COVID-19 Delays in Retina Care Are Driving Worse Vision Outcomes

Oct 15, 2021

Study details Port Delivery System with ranibizumab in nAMD

October 11, 2021 Lynda Charters In a presentation at the American Society of Retina Specialists 2021 annual meeting, Arshad Khanani, MD, MA, noted that investigators achieved results similar to those…

Study details Port Delivery System with ranibizumab in nAMD

Sep 13, 2021

New eyecare technology may be headed to the market

By Annette Gutierrez SARASOTA COUNTY (WSNN) – If you’re suffering from macular degeneration, there’s a new eye device that may be headed to the market. Medical experts say it could…

New eyecare technology may be headed to the market

Aug 26, 2021

Regeneron

REGENERON ANNOUNCES ENCOURAGING TOPLINE PHASE 2 DATA OF HIGH-DOSE AFLIBERCEPT IN WET AGE-RELATED MACULAR DEGENERATION TARRYTOWN, N.Y., Aug. 24, 2021 /PRNewswire/ — Phase 3 trials in wet AMD and diabetic macular edema…

Regeneron

Newsletter Sign-up

  • This field is for validation purposes and should be left unchanged.